Endo International plc (NASDAQ: ENDP), a generics and specialty branded pharmaceutical company, announced yesterday that it has named Laure Park as its new senior vice president, Investor Relations and Corporate Affairs, effective immediately.

Prior to joining Endo, Park spent 23 years at Quest Diagnostics where she held several leadership roles in different functional areas, including finance, investor relations and communications. Most recently, she served as Quest's vice president, Customer Experience. Prior to that, she was vice president, Communications & Investor Relations, responsible for leading investor relations and integrating it with the company's internal and external communications functions. She started her career in public accounting with Deloitte & Touche in 1987, before joining Quest's finance organisation in 1995. She is a member of the Healthcare Businesswomen's Association and has served as a director of the East Region of the American Cancer Society and the New Jersey Chapter of the Leukemia and Lymphoma Society.

Paul Campanelli, president and chief executive officer of Endo, said, 'I am excited to welcome Laure to lead Endo's Investor Relations and Corporate Affairs team. Given Laure's strong financial acumen, business leadership experience and communications background, she is well qualified for her new position, where she will serve as a member of Endo's executive leadership team. I'm confident Laure will make significant contributions to Endo and I look forward to working with her.'